1 |
150 mg double-blinded secukinumab |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
271 [1] 271 💬 |
2 |
150 mg open-label secukinumab |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
271 [1] 271 💬 |
3 |
300 mg double-blinded secukinumab |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
271 [1] 271 💬 |
4 |
Cosentyx |
- |
- |
- |
- |
041 [3] 41, 269, 271 💬 |
5 |
Cosentyx® |
- |
- |
- |
- |
269 [1] 269 💬 |
6 |
Secukinumab |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
013 [7] 13, 37, 41, 46, 160, 269, 271 💬 |
7 |
Secukinumab (150 mg) |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
271 [1] 271 💬 |
8 |
Secukinumab (75 mg) |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
271 [1] 271 💬 |
9 |
Secukinumab (ain457) |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
046 [1] 46 💬 |
10 |
Secukinumab (ain457) 150 mg s.c. |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
271 [1] 271 💬 |
11 |
Secukinumab 150 mg (2 injections per dose |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
269 [1] 269 💬 |
12 |
Secukinumab 150 mg provided in 1.0 ml pre-filled syringes (pfss) for sc injection. |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
271 [1] 271 💬 |
13 |
Secukinumab 150 mg/1 ml solution for injection |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
037 [2] 37, 271 💬 |
14 |
Secukinumab 150 milligram [cosentyx] |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
271 [1] 271 💬 |
15 |
Secukinumab 150mg |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
037 [1] 37 💬 |
16 |
Secukinumab 300 mg, s.c. |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
041 [1] 41 💬 |
17 |
Secukinumab 300mg |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
037 [1] 37 💬 |
18 |
Secukinumab 75 mg/0.5 ml solution for injection |
Secukinumab |
[1] D09967 D09967 💬 |
IL17A [1] IL17A 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation |
271 [1] 271 💬 |